摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

triphenyl<(2-tetrahydropyranyloxy)methyl>phosphonium chloride | 56061-88-2

中文名称
——
中文别名
——
英文名称
triphenyl<(2-tetrahydropyranyloxy)methyl>phosphonium chloride
英文别名
Oxan-2-yloxymethyl(triphenyl)phosphanium;chloride
triphenyl<(2-tetrahydropyranyloxy)methyl>phosphonium chloride化学式
CAS
56061-88-2
化学式
C24H26O2P*Cl
mdl
——
分子量
412.896
InChiKey
SNLLCSDUARMKPB-UHFFFAOYSA-M
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.49
  • 重原子数:
    28
  • 可旋转键数:
    6
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    18.5
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    (3aR,4S,6R,6aR)-tetrahydro-6-methoxy-2,2-dimethylfuro-[3,4-d][1,3]dioxole-4-carbaldehydetriphenyl<(2-tetrahydropyranyloxy)methyl>phosphonium chloride正丁基锂 作用下, 以 四氢呋喃正己烷 为溶剂, 以65%的产率得到methyl 5-deoxy-2,3-O-isopropylidene-6-O-(oxan-2-yl)-β-D-ribo-hex-5-enofuranoside
    参考文献:
    名称:
    甲基5-脱氧-5-(二羟基膦酰基)羟甲基-2,3-O-异亚丙基-β-d-呋喃呋喃糖苷的制备,d-核糖5-磷酸羟甲基类似物的前体
    摘要:
    摘要描述了5-脱氧-5-(二羟基膦基)羟甲基-d-核糖的前体的合成,5-doxy-(2-羟基膦基)羟甲基-d-核糖的等排类似物。该化合物与天然磷酸酯的不同之处在于,它掺入了膦酸残基来代替正磷酸酯单酯基,并且在将磷原子连接至分子碳水化合物部分的C原子上引入了羟基。该羟基的目的是向膦酸残基提供通常在天然磷酸酯的简单膦酸类似物中缺乏的亲水特性。
    DOI:
    10.1016/0008-6215(83)88078-1
点击查看最新优质反应信息

文献信息

  • Studies on the intramolecular competitive addition of carbon radicals to aldehydo and alkenyl groups
    作者:Richard Andrew Walton、Bert Fraser-Reid
    DOI:10.1021/ja00015a037
    日期:1991.7
    Cyclizations of ω-formylalkyl radicals can provide an efficient route to the corresponding cycloalkanols. However, if an ω-vinyl group is present an alternative mode of cyclization exists, and there is competition between cycloalkanol and methyl cycloalkane formation (i.e. (C=O) n versus (C=C) m ). Cyclohexanol formation, (C=O) 6 , usually overwhelms any alternative process, but cyclopentanol and methylcyclopentane
    ω-甲酰基烷基的环化可以为相应的环烷醇提供有效的途径。然而,如果存在ω-乙烯基,则存在另一种环化模式,并且环烷醇和甲基环烷烃形成之间存在竞争(即(C=O) n 与(C=C) m )。环己醇的形成,(C=O) 6 ,通常压倒任何替代工艺,但环戊醇和甲基环戊烷工艺((C=O) 5 和 (C=C) 5 )可能具有竞争力。后一个过程涉及经过充分研究的 5-己烯基自由基闭环,因此通过选择合适的底物,其中两种环化模式都是最佳的,我们获得了环戊醇 (C=O) 5 形成的速率数据直接-竞赛实验。kc=O ≥9.6×10 5 s -1 的值与Beckwith和Hay得到的值一致。
  • Synthesis and Properties of Substituted CBI Analogs of CC-1065 and the Duocarmycins Incorporating the 7-Methoxy-1,2,9,9a-tetrahydrocyclopropa[<i>c</i>]benz[<i>e</i>]indol-4-one (MCBI) Alkylation Subunit:  Magnitude of Electronic Effects on the Functional Reactivity
    作者:Dale L. Boger、Jeffrey A. McKie、Hui Cai、Barbara Cacciari、P. G. Baraldi
    DOI:10.1021/jo952033g
    日期:1996.1.1
    radical-alkene cyclization (24 --> 25, 32 --> 33) for completion of the synthesis of the 1,2-dihydro-3H-benz[e]indole skeleton and final Ar-3' alkylation of 28 for introduction of the activated cyclopropane. Two approaches to the implementation of the key 5-exo-trig free radical cyclization are detailed with the former proceeding with closure of 24 to provide 25 in which the required product functionalization was
    在以下文献中描述了7-甲氧基-1,2,9,9a-四氢环丙烷[c]苯并[e]吲哚-4-酮(MCBI)的合成,MCBI是带有对C4羰基的C7甲氧基的取代的CBI衍生物。努力确定对试剂的化学和功能反应性的潜在电子效应的大小。通过修饰的Stobbe缩合/ Friedel-Crafts酰化反应制备MCBI烷基化亚基的核心结构,以生成适当官能化的萘前体(15和20),然后进行5-exo-trig芳基自由基-烯烃环化(24-> 25、32-> 33)完成1,2-二氢-3H-苯并[e]吲哚骨架的合成,最后28的Ar-3'烷基化,以引入活化的环丙烷。详细介绍了实现关键的5-exo-trig自由基环化的两种方法,前者以24结束,以提供25,其中在环化之前引入了所需的产品功能化,而后者则用了环化产物的Tempo捕集器官能化的未反应的烯烃底物32提供33%。后一种简洁的方法以极好的总转化率(27-30%)以12-
  • Synthesis, Chemical Properties, and Preliminary Evaluation of Substituted CBI Analogs of CC-1065 and the Duocarmycins Incorporating the 7-Cyano-1,2,9,9a-tetrahydrocyclopropa[<i>c</i>]benz[<i>e</i>]indol-4-one Alkylation Subunit:  Hammett Quantitation of the Magnitude of Electronic Effects on Functional Reactivity
    作者:Dale L. Boger、Nianhe Han、Christine M. Tarby、Christopher W. Boyce、Hui Cai、Qing Jin、Paul A. Kitos
    DOI:10.1021/jo9605298
    日期:1996.1.1
    The synthesis of 7-cyano-1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-one (CCBI), a substituted CBI derivative bearing a C7 cyano group, is described in efforts that establish the magnitude of potential electronic effects on the functional reactivity of the agents. The CCBI alkylation subunit was prepared by a modified Stobbe condensation/Friedel-Crafts acylation for generation of the appropriately functionalized naphthalene precursors followed by 5-exo-trig aryl radical-alkene cyclization for synthesis of the 1,2-dihydro-3H-benz[e]indole skeleton and final Ar-3' alkylation for introduction of the activated cyclopropane. The most concise approach provided the CCBI subunit and its immediate precursor in 14-15 steps in superb overall conversions (15-20%). Resolution of an immediate CCBI precursor and its incorporation into both enantiomers of 34-39, analogs of CC-1065 and the duocarmycins, are detailed. A study of the solvolysis reactivity and regioselectivity of N-BOC-CCBI (25) revealed that introduction of the C7 nitrile slowed the rate of solvolysis but only to a surprisingly small extent. Classical Hammett quantitation of the effect provided a remarkably small rho (-0.3), indicating an exceptionally small C7 substituent electronic effect on functional reactivity. Additional kinetic studies of acid-catalyzed nucleophilic addition proved inconsistent with C4 carbonyl protonation as the slow and rate-determining step but consistent with a mechanism in which protonation is rapid and reversible followed by slow and rate-determining nucleophilic addition to the cyclopropane requiring both the presence and assistance of a nucleophile (S(N)2 mechanism). No doubt this contributes to the DNA alkylation selectivity of this class of agents and suggests that the positioning of an accessible nucleophile (adenine N3) and not C4 carbonyl protonation is the rate-determining step controlling the sequence selectivity of the DNA alkylation reaction, This small electronic effect on the solvolysis rate had no impact on the solvolysis regioselectivity, and stereoelectronically-controlled nucleophilic addition to the least substituted carbon of the activated cyclopropane was observed exclusively. Consistent with past studies, a direct relationship between solvolysis stability and cytotoxic potency was observed with the CCBI-derived agents providing the most potent analogs in the CBI series, and these observations were related to the predictable Hammett substituent effects. For the natural enantiomers, this unusually small electronic effect on functional reactivity had no perceptible effect on their DNA alkylation selectivity. Similar effects of the C7 cyano substituent on the unnatural enantiomers were observed, and they proved to be 4-10x more effective than the corresponding CBI-based unnatural enantiomers and 4-70x less potent than the CCBI natural enantiomers.
  • An improved synthesis of 1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-one (CBI): a simplified analog of the CC-1065 alkylation subunit
    作者:Dale L. Boger、Weiya Yun、Bradley R. Teegarden
    DOI:10.1021/jo00036a023
    日期:1992.5
    A concise and improved synthesis of 11, the immediate precursor to N-BOC-CBI and related analogues of CC-1065 incorporating the 1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-one alkylation subunit, is detailed based on a direct 5-exo-trig aryl radical-alkene cyclization for 3-hydroxymethylindoline generation.
  • EP0888301A4
    申请人:——
    公开号:EP0888301A4
    公开(公告)日:2002-05-08
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐